Alex Gadberry

AstraZeneca
Bioprocess Technologies & Engineering
Alex Gadberry is a Scientist on the Bioprocess Technologies and Engineering (BTE) team at AstraZeneca, specializing in perfusion cell culture process and technology development, scale-up, and technology transfer for the company’s integrated dynamic bioprocessing (IDB) platform. She has led the design and implementation of custom bioreactor and TFF systems, supported scale-up from bench to pilot, clinical, and commercial manufacturing scales, and collaborated cross-functionally to advance intensified perfusion processes. Alex has also worked extensively on automation, single-use technologies, and workflow optimization to improve scalability, robustness, and reproducibility across global sites. She holds an M.S. in Biopharmaceutical Process Engineering from Jefferson University and a B.S. in Chemical Engineering from the University of Arkansas.